Terms: = Ovarian cancer AND MECOM, MDS1-EVI1, EVI1, 2122, ENSG00000085276, Q03112, PRDM3
43 results:
1. The Origin of Highly Elevated Cell-Free DNA in Healthy Individuals and Patients with Pancreatic, Colorectal, Lung, or ovarian cancer.
Mattox AK; Douville C; Wang Y; Popoli M; Ptak J; Silliman N; Dobbyn L; Schaefer J; Lu S; Pearlman AH; Cohen JD; Tie J; Gibbs P; Lahouel K; Bettegowda C; Hruban RH; Tomasetti C; Jiang P; Chan KCA; Lo YMD; Papadopoulos N; Kinzler KW; Vogelstein B
Cancer Discov; 2023 Oct; 13(10):2166-2179. PubMed ID: 37565753
[TBL] [Abstract] [Full Text] [Related]
2. High evi1 and PARP1 expression as favourable prognostic markers in high-grade serous ovarian carcinoma.
Jank P; Leichsenring J; Kolb S; Hoffmann I; Bischoff P; Kunze CA; Dragomir MP; Gleitsmann M; Jesinghaus M; Schmitt WD; Kulbe H; Sers C; Stenzinger A; Sehouli J; Braicu IE; Westhoff C; Horst D; Denkert C; Gröschel S; Taube ET
J Ovarian Res; 2023 Jul; 16(1):150. PubMed ID: 37525239
[TBL] [Abstract] [Full Text] [Related]
3. Ultrasonographic features associated with previous torsion and the impact of surgery in managing neonatal ovarian cysts: a 20-year single-centre retrospective study.
Tyraskis A; Davidson J; Billington J; Blackburn S; Curry J; Mullassery D; Giuliani S; Eaton S; Cross K; De Coppi P
Pediatr Surg Int; 2023 Apr; 39(1):185. PubMed ID: 37095416
[TBL] [Abstract] [Full Text] [Related]
4. Machine learning approach informs biology of cancer drug response.
Zhu EY; Dupuy AJ
BMC Bioinformatics; 2022 May; 23(1):184. PubMed ID: 35581546
[TBL] [Abstract] [Full Text] [Related]
5. evi1 overexpression promotes ovarian cancer progression by regulating estrogen signaling.
Wang Z; Li Y; Wang N; Li P; Kong B; Liu Z
Mol Cell Endocrinol; 2021 Aug; 534():111367. PubMed ID: 34146645
[TBL] [Abstract] [Full Text] [Related]
6. Clinicopathological and molecular characteristics of endometrial neuroendocrine carcinomas reveal preexisting endometrial carcinoma origin.
Ono K; Kasajima R; Katayama K; Miyagi Y; Yokose T
Pathol Int; 2021 Aug; 71(8):491-499. PubMed ID: 34015161
[TBL] [Abstract] [Full Text] [Related]
7. PAX8 and mecom are interaction partners driving ovarian cancer.
Bleu M; Mermet-Meillon F; Apfel V; Barys L; Holzer L; Bachmann Salvy M; Lopes R; Amorim Monteiro Barbosa I; Delmas C; Hinniger A; Chau S; Kaufmann M; Haenni S; Berneiser K; Wahle M; Moravec I; Vissières A; Poetsch T; Ahrné E; Carte N; Voshol J; Bechter E; Hamon J; Meyerhofer M; Erdmann D; Fischer M; Stachyra T; Freuler F; Gutmann S; Fernández C; Schmelzle T; Naumann U; Roma G; Lawrenson K; Nieto-Oberhuber C; Cobos-Correa A; Ferretti S; Schübeler D; Galli GG
Nat Commun; 2021 Apr; 12(1):2442. PubMed ID: 33903593
[TBL] [Abstract] [Full Text] [Related]
8. Tumor genomic, transcriptomic, and immune profiling characterizes differential response to first-line platinum chemotherapy in high grade serous ovarian cancer.
Weberpals JI; Pugh TJ; Marco-Casanova P; Goss GD; Andrews Wright N; Rath P; Torchia J; Fortuna A; Jones GN; Roudier MP; Bernard L; Lo B; Torti D; Leon A; Marsh K; Hodgson D; Duciaume M; Howat WJ; Lukashchuk N; Lazic SE; Whelan D; Sekhon HS
Cancer Med; 2021 May; 10(9):3045-3058. PubMed ID: 33811746
[TBL] [Abstract] [Full Text] [Related]
9. The results of multigene panel sequencing in Slovak HBOC families.
Konecny M; Kosova K; Tilandyova P; Wachsmannova L; Baldovic M; Krajcovic J; Patlevicova A; Markus J; Ciernikova S
Neoplasma; 2021 May; 68(3):652-664. PubMed ID: 33724863
[TBL] [Abstract] [Full Text] [Related]
10. Multisite analysis of high-grade serous epithelial ovarian cancers identifies genomic regions of focal and recurrent copy number alteration in 3q26.2 and 8q24.3.
Ballabio S; Craparotta I; Paracchini L; Mannarino L; Corso S; Pezzotta MG; Vescio M; Fruscio R; Romualdi C; Dainese E; Ceppi L; Calura E; Pileggi S; Siravegna G; Pattini L; Martini P; Delle Marchette M; Mangioni C; Ardizzoia A; Pellegrino A; Landoni F; D'Incalci M; Beltrame L; Marchini S
Int J Cancer; 2019 Nov; 145(10):2670-2681. PubMed ID: 30892690
[TBL] [Abstract] [Full Text] [Related]
11. PBK, targeted by evi1, promotes metastasis and confers cisplatin resistance through inducing autophagy in high-grade serous ovarian carcinoma.
Ma H; Li Y; Wang X; Wu H; Qi G; Li R; Yang N; Gao M; Yan S; Yuan C; Kong B
Cell Death Dis; 2019 Feb; 10(3):166. PubMed ID: 30778048
[TBL] [Abstract] [Full Text] [Related]
12. Microarray-based identification of genes associated with prognosis and drug resistance in ovarian cancer.
Yin F; Yi S; Wei L; Zhao B; Li J; Cai X; Dong C; Liu X
J Cell Biochem; 2019 Apr; 120(4):6057-6070. PubMed ID: 30335894
[TBL] [Abstract] [Full Text] [Related]
13. Somatic copy number alterations have prognostic impact in patients with ovarian clear cell carcinoma.
Morikawa A; Hayashi T; Kobayashi M; Kato Y; Shirahige K; Itoh T; Urashima M; Okamoto A; Akiyama T
Oncol Rep; 2018 Jul; 40(1):309-318. PubMed ID: 29749539
[TBL] [Abstract] [Full Text] [Related]
14. Genetic heterogeneity after first-line chemotherapy in high-grade serous ovarian cancer.
Lambrechts S; Smeets D; Moisse M; Braicu EI; Vanderstichele A; Zhao H; Van Nieuwenhuysen E; Berns E; Sehouli J; Zeillinger R; Darb-Esfahani S; Cacsire Castillo-Tong D; Lambrechts D; Vergote I
Eur J Cancer; 2016 Jan; 53():51-64. PubMed ID: 26693899
[TBL] [Abstract] [Full Text] [Related]
15. Functional features of evi1 and evi1Δ324 isoforms of mecom gene in genome-wide transcription regulation and oncogenicity.
Sayadi A; Jeyakani J; Seet SH; Wei CL; Bourque G; Bard FA; Jenkins NA; Copeland NG; Bard-Chapeau EA
Oncogene; 2016 May; 35(18):2311-21. PubMed ID: 26234679
[TBL] [Abstract] [Full Text] [Related]
16. Referral of ovarian cancer Patients for Genetic Counselling by Oncologists: Need for Improvement.
Ricci MT; Sciallero S; Mammoliti S; Gismondi V; Franiuk M; Bruzzi P; Varesco L
Public Health Genomics; 2015; 18(4):225-32. PubMed ID: 26111740
[TBL] [Abstract] [Full Text] [Related]
17. [Expression of Annexin A1 in paclitaxel-resistant ovarian carcinoma and its clinical significance].
Zou L; Cao L; Yi H
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2014 Aug; 39(8):784-9. PubMed ID: 25202946
[TBL] [Abstract] [Full Text] [Related]
18. SUMO1 negatively regulates the transcriptional activity of evi1 and significantly increases its co-localization with evi1 after treatment with arsenic trioxide.
Singh S; Pradhan AK; Chakraborty S
Biochim Biophys Acta; 2013 Oct; 1833(10):2357-68. PubMed ID: 23770046
[TBL] [Abstract] [Full Text] [Related]
19. Prognostic value of tissue protein expression levels of MIB-1 (Ki-67) in Danish ovarian cancer patients. From the 'MALOVA' ovarian cancer study.
Heeran MC; Høgdall CK; Kjaer SK; Christensen L; Jensen A; Blaakaer J; Christensen IJ; Høgdall EV
APMIS; 2013 Dec; 121(12):1177-86. PubMed ID: 23594232
[TBL] [Abstract] [Full Text] [Related]
20. evi1 splice variants modulate functional responses in ovarian cancer cells.
Dutta P; Bui T; Bauckman KA; Keyomarsi K; Mills GB; Nanjundan M
Mol Oncol; 2013 Jun; 7(3):647-68. PubMed ID: 23517670
[TBL] [Abstract] [Full Text] [Related]
[Next]